Detailed View
AMRX - Amneal Pharmaceuticals, Inc.
Latest filing: 2026-03-31 | Reporting: gaap
Market Cap
5,722,418,176
Adj EBIT (TTM)
469,032,000
Enterprise Value
8,181,874,176
Last Price
17.92
Earnings Yield
5.73%
Return on Capital
27.86%
Capital
1,683,500,000
1Y Price Chart
Last Price: -
1Y Change: -
Company Summary
Loading summary...
| endDate | formType | fiscalYear | Revenue | OperatingIncomeLoss |
|---|---|---|---|---|
| 2026-03-31 | 10-Q | 2026 | 722,519,000 | 141,772,000 |
| 2025-12-31 | 10-K (Q4 derived) | 2025 | 814,319,000 | 112,033,000 |
| 2025-09-30 | 10-Q | 2025 | 784,513,000 | 70,344,000 |
| 2025-06-30 | 10-Q | 2025 | 724,508,000 | 111,372,000 |
| 2025-03-31 | 10-Q | 2025 | 695,420,000 | 100,347,000 |
| 2024-12-31 | 10-K (Q4 derived) | 2024 | 730,518,000 | 75,793,000 |
| 2024-09-30 | 10-Q | 2024 | 702,468,000 | 88,809,000 |
| 2024-06-30 | 10-Q | 2024 | 701,780,000 | 95,470,000 |
Notice something wrong?
Submit a quick report with a snapshot of the values you are seeing.